Clinical symptoms, comorbidities and complications in severe and non-severe patients with COVID-19
Zhufeng Wang,
No information about this author
Hongsheng Deng,
No information about this author
Changxing Ou
No information about this author
et al.
Medicine,
Journal Year:
2020,
Volume and Issue:
99(48), P. e23327 - e23327
Published: Nov. 23, 2020
The
pandemic
of
COVID-19
poses
a
challenge
to
global
healthcare.
mortality
rates
severe
cases
range
from
8.1%
38%,
and
it
is
particularly
important
identify
risk
factors
that
aggravate
the
disease.
Language: Английский
Aspects of pharmacotherapy with steroids in SARS-CoV-2 infection (literature review)
Experimental and Clinical Medicine,
Journal Year:
2024,
Volume and Issue:
93(1), P. 25 - 33
Published: March 31, 2024
In
recent
years,
the
SARS-CoV-2
pandemic
has
posed
a
significant
challenge
to
global
public
health.
Furthermore,
infection
with
can
result
in
acute
respiratory
distress
syndrome
due
excessive
systemic
inflammation,
leading
multiple
organ
failure
and
eventual
death.
of
reducing
specifically
by
decreasing
production
pro-inflammatory
cytokines
response
SARS-CoV-2,
remains
unresolved.
The
use
glucocorticosteroids
for
controversial.
Further
research
is
required
support
routine
steroids
intensive
care
protocols
as
current
basis
insufficient.
This
review
provides
an
analysis
literary
sources,
guidelines,
modern
international
recommendations
on
pathogenetic
therapy
prevent
eliminate
hyperproduction
using
glucocorticosteroid
agents.
aim
this
work
analyse
contemporary
sources
clinical
pharmacological
justification
practice
infection.
scientific
literature
indicates
that
cannot
be
recommended
therapeutic
patients
Thus,
mild
course
infection,
when
patient
does
not
need
oxygen
support,
are
contraindicated.
Whereas
severe
course,
failure,
their
absolutely
necessary,
they
mandatory
use.
There
generalised
definition
optimal
agent,
including
indications,
dosage,
duration
programs.
Keywords:
inflammatory
reaction,
proinflammatory
cytokines,
hypothalamic-pituitary-adrenal
system,
glucocorticosteroids.
Language: Английский
Clinical symptoms, comorbidities and complications features in severe and non-severe patients with COVID-19: a systematic review and meta-analysis without cases duplication
Zhufeng Wang,
No information about this author
Hongsheng Deng,
No information about this author
Changxing Ou
No information about this author
et al.
Research Square (Research Square),
Journal Year:
2020,
Volume and Issue:
unknown
Published: May 29, 2020
Abstract
Background:
The
pandemic
of
COVID-19
posed
a
challenge
to
global
healthcare.
mortality
rates
severe
cases
range
from
8.1%
31.8%,
and
it
is
particularly
important
identify
risk
factors
that
aggravate
the
disease.
Methods:
We
performed
systematic
review
literature
with
meta-analysis,
using
7
databases
assess
clinical
characteristics,
comorbidities
complications
in
non-severe
patients
COVID-19.
All
observational
studies
were
included.
random
or
fixed
effects
model
meta-analysis
calculate
pooled
proportion
95%
CI.
Measure
heterogeneity
was
estimated
by
Cochran’s
Q
statistic,
I
2
index
P
value.
Results:
4881
25
related
most
prevalent
comorbidity
hypertension
(severe:
33.4%,
CI:
25.4%
-
41.4%;
21.6%,
9.9%
33.3%),
followed
diabetes
14.4%,
11.5%
17.3%;
non-severe:
8.5%,
6.1%
11.0%).
prevalence
ARDS,
AKI
shock
all
higher
cases,
41.1%
(95%
14.1%
68.2%),
16.4%
3.4%
29.5%)
19.9%
5.5%
34.4%),
rather
than
3.0%
0.6%
5.5%),
2.2%
0.1%
4.2%)
4.1%
CI
-4.8%
13.1%)
patients,
respectively.
death
rate
(30.3%,
13.8%
46.8%)
(1.5%,
2.8%).
Conclusions:
Hypertension,
cardiovascular
diseases
may
be
for
develop
into
cases.
Language: Английский
CLINICAL AND PHARMACOLOGICAL ASPECTS OF APPLYING GLUCOCORTICOSTEROIDS FOR SARS-COVID-2 INFECTION: REVIEW ARTICLE
Андрій Вікторович Вахненко,
No information about this author
N.V. Moisieieva,
No information about this author
O. V. Vlasova
No information about this author
et al.
Актуальні проблеми сучасної медицини Вісник Української медичної стоматологічної академії,
Journal Year:
2024,
Volume and Issue:
24(1), P. 244 - 249
Published: March 20, 2024
In
recent
years,
the
SARS-CoV-2
pandemic
has
become
one
of
unexpected
and
very
serious
challenges
for
public
health
around
world.
Moreover,
infection
led
to
development
acute
respiratory
distress
syndrome
as
a
result
excessive
systemic
inflammation,
multiple
organ
failure,
later
death.
problem
eliminating
that
is,
reducing
production
pro-inflammatory
cytokines
in
SARS-CoV-2,
remains
open.
this
regard,
use
glucocorticosteroids
caused
by
quite
controversial.
The
basis
routine
steroids
intensive
care
protocols
is
clearly
insufficient
subject
further
research.
This
review
provides
an
analysis
literary
sources,
guidelines,
modern
international
recommendations
on
pathogenetic
therapy
prevent
eliminate
hyperproduction
using
glucocorticosteroid
agents.
purpose
work
conduct
sources
regarding
features
clinical
pharmacological
justification
practice.
scientific
literature
demonstrates
today
cannot
be
recommended
therapeutic
practice
patients
with
infection.
Thus,
mild
course
infection,
when
patient
does
not
need
oxygen
support,
GCS
contraindicated.
With
severe
develops
there
therapy,
mechanical
ventilation
or
ECMO,
corticosteroids
extremely
necessary,
may
mandatory
use.
There
pressing
comprehensive
definition
optimal
agent,
indications,
dosage,
duration
programs.
should
done
while
considering
biomarkers
severity
inflammatory
process
body's
response
Language: Английский
Lessons of the global COVID-19 pandemic in relation to the quality of education
O. V. Vlasova,
No information about this author
Н. В. Моисеева,
No information about this author
T.I. Yarmola
No information about this author
et al.
Medicine Today and Tomorrow,
Journal Year:
2024,
Volume and Issue:
93(1), P. 14 - 24
Published: March 31, 2024
The
global
COVID-19
pandemic
has
had
a
profound
impact
on
humanity,
affecting
not
only
physical
health
but
also
neurological,
social,
and
ecological
well-being.
Neurological
psychological
disorders
can
negatively
learning
quality
significantly
worsen
outcomes
for
higher
education
students.
aim
of
this
study
is
to
compare
the
prevalence
evaluate
symptoms
post-COVID-19
syndrome
among
senior
students
in
two
educational
institutions,
Poltava
State
Medical
University
National
Pedagogical
named
after
V.G.
Korolenko.
these
will
be
assessed
through
analysis
author's
questionnaire.
Rehabilitation
measures
recommended
improve
process.
It
been
determined
that
there
high
level
damage
nervous
system
from
both
universities,
which
accompanied
by
combination
including
headache,
memory
impairment,
insomnia,
anxiety,
unmotivated
weakness,
excessive
fatigue.
aforementioned
complaints
need
increase
time
completing
tasks
illness,
along
with
impairment
sleep
disturbances,
suggest
academic
performance,
state,
psychosomatic
background
are
at
low
level.
Therefore,
recommendations
cognitive
rehabilitation
category
applicants
necessary,
taking
into
account
their
significant
load.
samples
were
made
year
Physical
activity
levels
may
exacerbate
symptoms.
Recommendations
patient
group
necessary.
Applicants
experiencing
increased
fatigue,
reduced
work
capacity,
mood
instability
should
review
organization
process
distance
conditions
make
changes
lifestyle.
Keywords:
syndrome,
long
COVID-19,
trucker
syndrome.
Language: Английский
STRATEGIES TO MITIGATE THE IMPACT OF POST-COVID-19 SYNDROME ON HIGHER EDUCATION QUALITY
T.I. Yarmola,
No information about this author
O. V. Vlasova,
No information about this author
Lidiia Tkachenko
No information about this author
et al.
Актуальні проблеми сучасної медицини Вісник Української медичної стоматологічної академії,
Journal Year:
2024,
Volume and Issue:
24(2), P. 200 - 206
Published: May 20, 2024
The
SARS-CoV-2
pandemic
has
left
a
profound
impact
not
only
on
the
physical
health
of
humanity
but
also
neurological,
social,
and
ecological
well-being.
Neurological
psychological
disorders
resulting
from
have
negatively
affected
quality
learning
significantly
worsened
outcomes
among
students
in
higher
education
institutions.
purpose
this
study
is
to
compare
prevalence
evaluate
symptoms
post-COVID
syndrome,
identify
their
senior
two
educational
institutions:
Poltava
State
Medical
University
National
Pedagogical
named
after
V.G.
Korolenko.
It
been
observed
that
damage
nervous
system
simultaneous
appearance
combination
including
headache,
memory
impairment,
insomnia,
anxiety,
unmotivated
weakness,
excessive
fatigue
are
high
both
universities.
aforementioned
complaints,
along
with
need
for
increased
time
complete
tasks
post-illness,
sleep
disturbances,
indicate
academic
performance,
state,
psychosomatic
background
at
low
level.
Therefore,
it
essential
develop
recommendations
cognitive
rehabilitation
tailored
group
students,
considering
significant
workload
(samples
were
collected
students).
Moreover,
moderate
activity
levels
may
exacerbate
post-COVID-19
necessitating
development
rehabilitation.
Students
experiencing
fatigue,
reduced
work
capacity,
mood
instability
should
consider
reviewing
organization
process,
especially
distance
conditions,
making
lifestyle
changes
accordingly.
thoroughly
elaborated
healthcare
measures
enhance
process
be
implemented
into
practice.
Language: Английский
ANALYSIS OF THE SPECTRUM OF RESPIRATORY TRACT MICROFLORA IN PATIENTS WITH RESPIRATORY INFECTIONS FOR 2018-2023
Актуальні проблеми сучасної медицини Вісник Української медичної стоматологічної академії,
Journal Year:
2024,
Volume and Issue:
24(4), P. 58 - 62
Published: Dec. 26, 2024
The
COVID-19
pandemic
has
undoubtedly
affected
the
spectrum
of
microorganisms,
their
resistance
to
antibiotics,
emergence
multidrug-resistant
strains
and
increased
consumption
antibiotics
by
patients
with
in
hospitals.
data
from
world
national
literature
on
dynamics
respiratory
microflora
context
are
currently
incomplete
contradictory.
purpose
study
is
analyse
patients'
tract
for
period
2018-2023.
A
retrospective
analysis
results
microbiological
monitoring
microorganisms
isolated
biomaterials
2770
acute
diseases
2018
2023
was
conducted
based
obtained
Poltava
Regional
Clinical
Infectious
Diseases
Hospital
Council.
It
found
out
that
before
2018-2019
pandemic,
coccal
represented
S.
aureus,
pneumoniae,
haemolyticus,
Agalacticae,
predominantly
recorded
among
pathogens.
During
2020-2023,
pathogens
changed
characterised
an
increase
proportion
C.
albicans,
Enterococcus
spp.,
K.
pneumoniae.
When
comparing
2020-2021
period,
which
irrational
use
antimicrobials,
2022-2023,
when
began
be
used
more
moderately,
differences
were
also
identified
microbial
landscape.
In
compared
2020-2021,
there
again
a
trend
towards
microflora,
particular
pyogenes
spp.
Acinetobacter,
decrease
albicans
haemolyticus.
Thus,
prior
(S.
agalacticae)
dominated
change
fungal
hospital-acquired
(C.
pneumoniae).
analyzing
it
revealed
tendency
Acinetobacter)
Language: Английский